Myriad Genetics MYGN
NASDAQ MYGN
$4.54 +0.48 (+11.82%)
At close: Oct 2, 2026 · 4:00 PM EDT

Myriad Genetics (MYGN) Sales of Property, Plant and Equipment (2021)

Updated

Myriad Genetics (MYGN) reported Sales of Property, Plant and Equipment of $346.6 million for Q3 2021.

Analysis

Myriad Genetics (MYGN) Sales of Property, Plant and Equipment (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 HCA Healthcare 93.08 Bn 92.52 Bn - -
2 Natera 58.93 Bn 54.61 Bn 485.19 Mn -
3 Quest Diagnostics 25.75 Bn 24.18 Bn 1.03 Bn -
4 Labcorp Holdings 24.96 Bn 22.73 Bn 1.11 Bn 1.90 Mn
5 Guardant Health 23.76 Bn 19.82 Bn 219.03 Mn -
6 Tenet Healthcare 20.83 Bn 11.98 Bn - -
7 Tempus AI 13.43 Bn 10.46 Bn 246.50 Mn -
8 BrightSpring Health Services 11.90 Bn 10.24 Bn 492.75 Mn -
9 Encompass Health 11.82 Bn 12.29 Bn - -
10 Myriad Genetics 434.02 Mn -100.58 Mn 127.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 346.60 Mn
API Access

Myriad Genetics Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=MYGN&period=max&api_key=YOUR_API_KEY